Cargando…

Metabolomics of Breast Cancer: A Review

Breast cancer is the most commonly diagnosed cancer in women worldwide. Major advances have been made towards breast cancer prevention and treatment. Unfortunately, the incidence of breast cancer is still increasing globally. Metabolomics is the field of science which studies all the metabolites in...

Descripción completa

Detalles Bibliográficos
Autores principales:	Subramani, Ramadevi, Poudel, Seeta, Smith, Kenneth D., Estrada, Adriana, Lakshmanaswamy, Rajkumar
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2022
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9325024/ https://www.ncbi.nlm.nih.gov/pubmed/35888767 http://dx.doi.org/10.3390/metabo12070643

Ejemplares similares

Classical and Non-Classical Progesterone Signaling in Breast Cancers
por: Pedroza, Diego A., et al.
Publicado: (2020)

Involvement of actin cytoskeletal modifications in the inhibition of triple-negative breast cancer growth and metastasis by nimbolide
por: Arumugam, Arunkumar, et al.
Publicado: (2021)

miRNome and Functional Network Analysis of PGRMC1 Regulated miRNA Target Genes Identify Pathways and Biological Functions Associated With Triple Negative Breast Cancer
por: Pedroza, Diego A., et al.
Publicado: (2021)

Progesterone receptor membrane component 1 promotes the growth of breast cancers by altering the phosphoproteome and augmenting EGFR/PI3K/AKT signalling
por: Pedroza, Diego A., et al.
Publicado: (2020)

Emerging roles of microRNAs in pancreatic cancer diagnosis, therapy and prognosis (Review)
por: SUBRAMANI, RAMADEVI, et al.
Publicado: (2015)

MicroRNA-125a influences breast cancer stem cells by targeting leukemia inhibitory factor receptor which regulates the hippo signaling pathway
por: Nandy, Sushmita Bose, et al.
Publicado: (2015)

microRNA alterations in ALDH positive mammary epithelial cells: a crucial contributing factor towards breast cancer risk reduction in case of early pregnancy
por: Bose Nandy, Sushmita, et al.
Publicado: (2014)

Targeting Insulin-Like Growth Factor 1 Receptor Inhibits Pancreatic Cancer Growth and Metastasis
por: Subramani, Ramadevi, et al.
Publicado: (2014)

Silencing growth hormone receptor inhibits estrogen receptor negative breast cancer through ATP-binding cassette sub-family G member 2
por: Arumugam, Arunkumar, et al.
Publicado: (2019)

The serum protein profile of early parity which induces protection against breast cancer
por: Bracamontes, Christina Gutierrez, et al.
Publicado: (2016)

Hypoxanthine Phosphoribosyl Transferase 1 Is Upregulated, Predicts Clinical Outcome and Controls Gene Expression in Breast Cancer
por: J. Sedano, Melina, et al.
Publicado: (2020)

Pregnancy Inhibits Mammary Carcinogenesis by Persistently Altering the Hypothalamic–Pituitary Axis
por: Subramani, Ramadevi, et al.
Publicado: (2021)

Gedunin inhibits pancreatic cancer by altering sonic hedgehog signaling pathway
por: Subramani, Ramadevi, et al.
Publicado: (2016)

Growth hormone receptor inhibition decreases the growth and metastasis of pancreatic ductal adenocarcinoma
por: Subramani, Ramadevi, et al.
Publicado: (2014)

Phytochemicals as an Alternative or Integrative Option, in Conjunction with Conventional Treatments for Hepatocellular Carcinoma
por: Rodriguez, Sheryl, et al.
Publicado: (2021)

Hepatocyte nuclear factor 1 alpha influences pancreatic cancer growth and metastasis
por: Subramani, Ramadevi, et al.
Publicado: (2020)

The Prevalence of Genital Human Papillomavirus Subtypes in a Cohort of Hispanic Women Presenting for Cervical Cancer Screening Along the US-Mexico Border
por: Shokar, Navkiran K., et al.
Publicado: (2020)

Nimbolide inhibits pancreatic cancer growth and metastasis through ROS-mediated apoptosis and inhibition of epithelial-to-mesenchymal transition
por: Subramani, Ramadevi, et al.
Publicado: (2016)

Glucose insult elicits hyperactivation of cancer stem cells through miR-424–cdc42–prdm14 signalling axis
por: Nandy, Sushmita Bose, et al.
Publicado: (2017)

FOXC1 plays a crucial role in the growth of pancreatic cancer
por: Subramani, Ramadevi, et al.
Publicado: (2018)

Hyperglycemia Enhances the Proliferation of Non-Tumorigenic and Malignant Mammary Epithelial Cells through Increased leptin/IGF1R Signaling and Activation of AKT/mTOR
por: Lopez, Rebecca, et al.
Publicado: (2013)

The role of hormones and aromatase inhibitors on breast tumor growth and general health in a postmenopausal mouse model
por: Arumugam, Arunkumar, et al.
Publicado: (2014)

Salivary Metabolomics for Oral Cancer Detection: A Narrative Review
por: Panneerselvam, Karthika, et al.
Publicado: (2022)

Nimbolide Inhibits SOD2 to Control Pancreatic Ductal Adenocarcinoma Growth and Metastasis
por: Mehmetoglu-Gurbuz, Tugba, et al.
Publicado: (2023)

Gustatory Receptors Required for Avoiding the Toxic Compound Coumarin in Drosophila melanogaster
por: Poudel, Seeta, et al.
Publicado: (2016)

Impaired Taste Associative Memory and Memory Enhancement by Feeding Omija in Parkinson’s Disease Fly Model
por: Poudel, Seeta, et al.
Publicado: (2018)

Sending a Message: Use of mRNA Vaccines to Target the Tumor Immune Microenvironment
por: Ramirez, Fabiola, et al.
Publicado: (2023)

Application of metabolomics in the diagnosis of breast cancer: a systematic review
por: Yang, Liqing, et al.
Publicado: (2020)

A genomics approach to identify susceptibilities of breast cancer cells to “fever-range” hyperthermia
por: Amaya, Clarissa, et al.
Publicado: (2014)

A Review of Applications of Metabolomics in Cancer
por: Beger, Richard D.
Publicado: (2013)

Precision Oncology via NMR-Based Metabolomics: A Review on Breast Cancer
por: Vignoli, Alessia, et al.
Publicado: (2021)

Metabolomics-Microbiome Crosstalk in the Breast Cancer Microenvironment
por: Al-Ansari, Mysoon M., et al.
Publicado: (2021)

Breast Cancer Metabolomics: From Analytical Platforms to Multivariate Data Analysis. A Review
por: Silva, Catarina, et al.
Publicado: (2019)

Receptor activator for nuclear factor-κB ligand signaling promotes progesterone-mediated estrogen-induced mammary carcinogenesis
por: Boopalan, Thiyagarajan, et al.
Publicado: (2015)

Application of Metabolomics in Drug Resistant Breast Cancer Research
por: Shajahan-Haq, Ayesha N., et al.
Publicado: (2015)

Metabolomics: a promising diagnostic and therapeutic implement for breast cancer
por: Chen, Zhanghan, et al.
Publicado: (2019)

HOTAIR: a potential metastatic, drug-resistant and prognostic regulator of breast cancer
por: Raju, Ganji Seeta Rama, et al.
Publicado: (2023)

Nutritional Metabolomics in Diet–Breast Cancer Relations: Current Research, Challenges, and Future Directions—A Review
por: Vahid, Farhad, et al.
Publicado: (2023)

HR-MAS NMR Based Quantitative Metabolomics in Breast Cancer
por: Gogiashvili, Mikheil, et al.
Publicado: (2019)

Metabolomics and EMT Markers of Breast Cancer: A Crosstalk and Future Perspective
por: Pal, Ajay Kumar, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_ffp05btrdkgelgq9m1frd9nfme